Back to Search Start Over

Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.

Authors :
Linsley PS
Greene JL
Brady W
Bajorath J
Ledbetter JA
Peach R
Source :
Immunity [Immunity] 1994 Dec; Vol. 1 (9), pp. 793-801.
Publication Year :
1994

Abstract

B7-0 or B7-2 (CD86) is a T cell costimulatory molecule that binds the same receptors (CD28 and CTLA-4) as B7-1 (CD80), but shares with it only approximately 25% sequence identity and is expressed earlier during an immune response. Here we show that human CD86 maintains similar (within approximately 2- to 3-fold) overall receptor binding and T cell costimulatory properties as CD80. However, CD80 and CD86 did not bind equivalently to CTLA-4: CD80 bound Y100A, a form of CTLA4lg with a mutation in the CDR3-like region, > 200-fold better than did CD86; inhibition of CD80-mediated cellular responses required approximately 100-fold lower CTLA4lg concentrations; and CD80-CTLA4lg complexes dissociated 5- to 8-fold more slowly, Thus, CD80 and CD86 utilize different binding determinants and have different kinetics of binding to CD28 and CTLA-4.

Details

Language :
English
ISSN :
1074-7613
Volume :
1
Issue :
9
Database :
MEDLINE
Journal :
Immunity
Publication Type :
Academic Journal
Accession number :
7534620
Full Text :
https://doi.org/10.1016/s1074-7613(94)80021-9